July 29, 2021 10:45 pm | Updated 10:45 pm IST - MUMBAI
The initial public offering (IPO) of Windlas Biotech Ltd., a maker of pharma formulations, will open on August 4. The price band has been fixed at ₹448 to ₹460 per equity share of the face value of ₹5. Bids can be made for a minimum of 30 shares and in multiples of 30 shares thereafter. The IPO comprises fresh issue of up to ₹165 crore and an offer for sale of up to 5,142,067 shares by selling investors.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
